CBC India provides outsourcing service for a wide range of active pharmaceutical ingredients (API) and intermediates. In addition to our business as a trading company, we are expanding as a manufacturer with the development of cutting-edge technology and our original research together with our partner companies in each field. CBC India is actively developing overseas business aiming at creating a society in which people can enjoy a healthy and prosperous lifestyle.
Drawing on our strong overseas network, we are supplying Active pharmaceutical ingredients and intermediates from around the world as well as from our subsidiary company in Italy, Procos.
- Procos S.p.A. is our wholly owned subsidiary, specializing in the development, scale-up and production of Active Pharmaceutical Ingredients (APIs), advanced intermediates and related services for the pharmaceutical industry wherein our core business sectors include custom synthesis and Generic API manufacturing
- Located over an area of 110,000 sq. meter on the outskirts of Milan, Italy;
our manufacturing site has a cutting-edge multipurpose plant, fully designed under cGMP compliance and successfully audited and approved by USFDA, AIFA and PMDA
- With eye on the future, we have commissioned in 2015 a new block R10 – High Potency Cytotoxic APIs production unit for manufacturing oncology molecules
- Please Visit Procos S.p.A. website to know more http://www.procos.it
- Sourcing APIs for Japan, China, USA and ASEAN
- Sales of Procos APIs to Indian Generic companies for Regulated Markets
- Facilitating Contract Reseach and Contract Manufacturing of APIs
- Sourcing Dossiers for ASEAN and CIS Market
- Registering Dossiers for ASEAN Market
- Sourcing Intermediates for Global Market
- Facilitating Contract Manufacturing of Intermediates